Dihexa vs Melanotan II

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

DihexaMelanotan II
CategoryPeptidesPeptides
Standard DoseResearch indicates 10-20 mg daily via oral or sublingual administration.Research indicates 250-500 mcg daily via subcutaneous injection during loading, reducing to 250 mcg 2-3 times weekly for maintenance.
TimingMorning dosing preferred. Can be taken with or without food (orally active).Administer 4-6 hours before UV exposure for optimal tanning synergy. Can be taken at any time of day.
Cycle Duration2-4 week cycles with equal rest periods. Long-term safety data is extremely limited.Loading phase 1-2 weeks, then maintenance as long as desired. Pigmentation fades gradually upon discontinuation.
Evidence Levelanimal_plus_anecdotalmoderate_human
A

Dihexa

Peptides

Mechanism

Dihexa (N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide) is an orally active, blood-brain barrier-permeable oligopeptide derived from angiotensin IV. It binds hepatocyte growth factor (HGF) with high affinity, inhibiting HGF dimerization and synergistically promoting c-Met receptor phosphorylation and signaling. Activation of HGF/c-Met drives procognitive effects through increased dendritic arborization, spinogenesis, and synaptogenesis via the PI3K/AKT signaling pathway. Research indicates it is approximately 10 million times more potent than BDNF for new synapse formation.

Standard Dosing

Research indicates 10-20 mg daily via oral or sublingual administration.

Timing

Morning dosing preferred. Can be taken with or without food (orally active).

Cycle Duration

2-4 week cycles with equal rest periods. Long-term safety data is extremely limited.

Side Effects

  • Headache
  • Jaw tension
  • Increased emotional sensitivity (anecdotal)
  • Potential for excessive synaptogenesis (theoretical long-term concern)

Contraindications

  • Active cancer (HGF/c-Met pathway promotes tumor growth)
  • Pregnancy and breastfeeding
  • History of cancer

Best Stacking Partners

SemaxP21NSI-189
B

Melanotan II

Peptides

Mechanism

Melanotan II is a synthetic cyclic analog of alpha-melanocyte-stimulating hormone (alpha-MSH) that non-selectively agonizes melanocortin receptors MC1, MC3, MC4, and MC5. MC1R activation stimulates eumelanin synthesis through tyrosinase upregulation, producing tanning. MC3R activation in the CNS increases libido and produces erectile responses. MC4R activation suppresses appetite. The cyclic structure provides enhanced in vivo stability (half-life 1-2 hours) and increased blood-brain barrier permeability compared to linear alpha-MSH.

Standard Dosing

Research indicates 250-500 mcg daily via subcutaneous injection during loading, reducing to 250 mcg 2-3 times weekly for maintenance.

Timing

Administer 4-6 hours before UV exposure for optimal tanning synergy. Can be taken at any time of day.

Cycle Duration

Loading phase 1-2 weeks, then maintenance as long as desired. Pigmentation fades gradually upon discontinuation.

Side Effects

  • Nausea (common, especially during loading)
  • Facial flushing
  • Spontaneous erections
  • Appetite suppression
  • Darkening of existing moles (monitor closely)
  • Fatigue
  • New nevus formation

Contraindications

  • History of melanoma or atypical moles
  • Active skin cancer
  • Pregnancy and breastfeeding
  • Addison's disease
  • Pheochromocytoma

Best Stacking Partners

PT-141

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →